Seno Medical Instruments, Inc. CEO Janet Campbell Wins Gold Stevie® Award in 2013 Stevie Awards for Women in Business

SAN ANTONIO, Nov. 21, 2013 /PRNewswire/ -- Seno Medical Instruments, Inc., the company pioneering opto-acoustic imaging as a tool to improve the diagnosis of cancer, today announced that CEO Janet Campbell has been named the winner of a Gold Stevie® Award for Female Entrepreneur of the Year in the 10th annual Stevie Awards for Women in Business 2013. Ms. Campbell received the honor in the consumer products category representing companies with 11 to 2,500 employees.

The Stevie Awards for Women in Business are the world's top honors for female entrepreneurs, executives, employees and the organizations they run. All individuals and organizations worldwide are eligible to submit nominations – public and private, for-profit and non-profit, large and small. The 2013 awards received entries from 18 nations and territories. More than 1,200 nominations from organizations of all sizes and in virtually every industry were submitted this year.

"When my  mother died of lung cancer, I dedicated myself to finding a way to make  a significant impact on the fight against cancer by saving lives. It was with this goal in mind that I founded Seno Medical Instruments, to advance and develop a new imaging modality – called Imagio – based on opto-acoustic technology that could potentially improve how cancer is diagnosed," said Janet. "I am honored to accept this award, and would like to sincerely thank the Stevie Awards judges for recognizing the work our company has accomplished so far."

Imagio is an investigational opto-acoustic imaging system that may help women with benign breast masses avoid negative, invasive biopsies. It combines traditional ultrasound with an imaging technology based on light in and sound out called "opto-acoustics." The opto-acoustic images provide a unique blood map in and around suspicious breast masses. Unlike other imaging modalities, Imagio doesn't expose patients to potentially harmful ionizing radiation (x-rays) or injectable contrast agents.

Because cancerous tumors grow relatively quickly, they require significant amounts of blood and oxygen, so a network of blood vessels grows around cancerous masses. Radiologists believe that Imagio images depicting significant vascular structures and low oxygen levels are likely to indicate cancer.

Seno is currently enrolling patients into the Imagio Pivotal Study, which will include 16 leading hospitals and imaging centers throughout the United States.

About the Stevie Awards

Stevie Awards are conferred in five programs: the Asia-Pacific Stevie Awards, The International Business Awards, The American Business Awards, the Stevie Awards for Women in Business, and the Stevie Awards for Sales & Customer Service. Honoring organizations of all types and sizes and the people behind them, the Stevies recognize outstanding performances in the workplace worldwide. Learn more about The Stevie Awards at www.StevieAwards.com.

About SENO Medical Instruments, Inc.

Seno Medical Instruments, Inc. is a San Antonio, Texas-based medical imaging company committed to the development and commercialization of a new standard in cancer diagnosis: opto-acoustic imaging. Seno's Imagio™ breast imaging system uses opto-acoustic technology co-registered with ultrasound to generate functional and anatomical images of the breast. The opto-acoustic images provide a unique blood map around suspicious breast masses while the ultrasound provides a traditional anatomic image. Through the appearance or absence of the two hallmark indicators of cancer – angiogenesis and deoxygenation – Seno believes that Imagio images will be a more effective tool to help radiologists confirm or rule out malignancy than current diagnostic imaging modalities – without exposing patients to potentially harmful ionizing radiation or contrast agents. Seno's platform technology may also address other disease applications. To learn more about Seno Medical's opto-acoustic imaging technology and applications, visit www.SenoMedical.com.

SOURCE Seno Medical Instruments, Inc.